CUE vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 18, 2026

CUE

38.3
AI Score
VS
CLYM Wins

CLYM

64.5
AI Score

Investment Advisor Scores

CUE

38score
Recommendation
SELL

CLYM

65score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CUE CLYM Winner
Net Income -26.60M -27.22M CUE
Operating Income -26.55M -30.57M CUE
ROE -100.6% -11.4% CLYM
ROA -63.0% -11.1% CLYM
Total Assets 42.21M 246.29M CLYM
Cash 27.14M 44.11M CLYM
Current Ratio 2.74 31.45 CLYM
Free Cash Flow -21.86M -25.18M CUE

Relative Price Performance (Last 90 Days)

CUE 1M: -5.2% · 3M: -21.3% CLYM 1M: -27.3% · 3M: -17.6%

Current Technical Phase

CUE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.7%), weak momentum, RSI 43

RSI (14): 42.8 · Price: $25.57

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 30

RSI (14): 30.3 · Price: $10.94

Fundamentals Snapshot

Metric CUE CLYM
Market Cap — —
Forward P/E -3.4 -10.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 1.7% 0.0%
Gross Margin -1.0% —
Operating Margin -11.1% 0.0%
EPS -28.67 -0.79
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.